Tyropanoate

VARIOUS

Key facts

Tyropanoate is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1969. Recorded indications include Diagnostic aid.

• Approval status: ofm (first approved 1969 by the FDA).
• Indications: Diagnostic aid.
• ATC code: V08AC09 (Watersoluble, hepatotropic X-ray contrast media).
• Molecular formula: C15H18I3NO3; molecular weight 641.03 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Diagnostic aid

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1969-10-24	FDA	—	—

ATC classification

ATC code	Therapeutic hierarchy
V08AC09	VARIOUS › CONTRAST MEDIA › X-RAY CONTRAST MEDIA, IODINATED › Watersoluble, hepatotropic X-ray contrast media

Chemical structure

• Molecular formula: C₁₅H₁₈I₃NO₃
• Molecular weight: 641.03 g/mol
• CAS number: 27293-82-9
• InChIKey: YMOXVLQZFAUUKI-UHFFFAOYSA-N
• PubChem CID: 131884085

CCCC(=O)NC1=C(I)C=C(I)C(CC(CC)C(O)=O)=C1I

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tyropanoate used for?

DrugCentral lists the following indications for Tyropanoate: Diagnostic aid.

When was Tyropanoate first approved?

Tyropanoate was first approved by the FDA in 1969.

What is the chemical formula of Tyropanoate?

Tyropanoate has the molecular formula C15H18I3NO3 and a molecular weight of 641.03 g/mol.

Sources

• DrugCentral drug card 2785 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1200899 — compound record and bioactivity
• PubChem CID 131884085 — chemical identifiers
• DrugBank DB09340 — drug record
• FDA UNII XRJ0P5FAYO — substance identity
• DailyMed: FDA labels for Tyropanoate — current prescribing information (label search)

How this page is built: methodology · editorial policy & corrections.